ESR1 and breast carcinoma: As most breast cancer patients are post-menopausal, have ER+ tumor status, and receive anti-estrogen therapy, the inclusion of these aspects in a model of breast cancer enhances validity, particularly given the known role of estrogen in mood, cognition, and brain structure (36–39).